Evidence map›Paper›PMID 25721812›Full record

ReviewSeminars in cell & developmental biology2015

Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes.

Valentina R Minciacchi, Michael R Freeman, Dolores Di Vizio

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in cell & developmental biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 590 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
590citing papers in PubMed, 5 pooled it
28.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

590 citing papers in PubMed, 5 syntheses or guidelines pooled it, 934 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Extracellular vesicles: Navigating new frontiers in glioblastoma therapy.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

530 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Valentina R MinciacchiDivision of Cancer Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Michael R FreemanDivision of Cancer Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; The Urological Diseases Research Center; Boston Children's Hospital, Boston, MA, United States; Department of Surgery, Harvard Medical School, Boston, MA, United States.
Dolores Di VizioDivision of Cancer Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; The Urological Diseases Research Center; Boston Children's Hospital, Boston, MA, United States; Department of Surgery, Harvard Medical School, Boston, MA, United States. Electronic address: Dolores.Divizio@cshs.org.
Cedars-Sinai Medical Center · USBoston Children's Hospital · US

Funding

UCLA SPORE IN PROSTATE CANCERP50CA092131 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FREEMAN, MICHAEL R · 2002 to 2023
$42.6M
Cholesterol and Prostate HealthR01DK087806 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI FREEMAN, MICHAEL R · 2011 to 2015
$1.9M
Amoeboid Membrane Dynamics in Prostate CancerR01CA143777 · NCI · CEDARS-SINAI MEDICAL CENTER · PI FREEMAN, MICHAEL R · 2010 to 2014
$1.7M
Membrane Microdomains in Prostate CancerR01CA112303 · NCI · CHILDREN'S HOSPITAL BOSTON · PI FREEMAN, MICHAEL R · 2005 to 2009
$1.4M
Fatty Acid Synthase, Caveolin-1 and Membrane Microdomains in Prostate CancerR00CA131472 · NCI · CEDARS-SINAI MEDICAL CENTER · PI DI VIZIO, DOLORES · 2010 to 2012
$722k
NCI NIH HHS CA112303NCI NIH HHS NCI NIH R00 CA131472NCI NIH HHS NIH P50 CA092131NCI NIH HHS P50 CA092131NCI NIH HHS R00 CA131472NCI NIH HHS R01 CA112303NCI NIH HHS R01 CA143777NIDDK NIH HHS R01 DK087806PHS HHS NIDDK R3747556
6 · The paper itself

Abstract

Since their first description, extracellular vesicles (EVs) have been the topic of avid study in a variety of physiologic contexts and are now thought to play an important role in cancer. The state of knowledge on biogenesis, molecular content and horizontal communication of diverse types of cancer EVs has expanded considerably in recent years. As a consequence, a plethora of information about EV composition and molecular function has emerged, along with the notion that cancer cells rely on these particles to invade tissues and propagate oncogenic signals at distance. The number of in vivo studies, designed to achieve a deeper understanding of the extent to which EV biology can be applied to clinically relevant settings, is rapidly growing. This review summarizes recent studies on cancer-derived EV functions, with an overview about biogenesis and molecular cargo of exosomes, microvesicles and large oncosomes. We also discuss current challenges and emerging technologies that might improve EV detection in various biological systems. Further studies on the functional role of EVs in specific steps of cancer formation and progression will expand our understanding of the diversity of paracrine signaling mechanisms in malignant growth.

Indexed as

AnimalsCell-Derived MicroparticlesExosomesExtracellular VesiclesHumansNeoplasmsNeovascularization, PathologicBiogenesisExosomesExtracellular communicationExtracellular vesiclesLarge oncosomesMicrovesicles

Identifiers

PMID25721812
PMCPMC4747631
OpenAlexW2038744035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.